Press Releases

 

Belharra Therapeutics Debuts With $130 Million in Funding
January 4, 2023
Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas
January 4, 2023